Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» September 2011
September 2011
First Phase III trial of an alpha-pharmaceutical
First Phase III trial of an alpha-pharmaceutical
eurekalert.org
Bone metastases
prostate cancer
Alpharadin
Algeta
Bayer
U.S. FDA guidance on biosimilars may be imminent
U.S. FDA guidance on biosimilars may be imminent
HealthNews
FDA
biosimilars
Teva announces pharmaceutical sales deal with Washington-based CDI
Teva announces pharmaceutical sales deal with Washington-based CDI
medreps
Teva Pharmaceuticals
Cocrystal Discovery Incorporated
anti-viral
hepatitis C
Isis Pharma files patent suit against Santaris
Isis Pharma files patent suit against Santaris
North Country Times, CA
Isis Pharmaceuticals
Santaris
Fitch Downgrades Pfizer’s Debt
Fitch Downgrades Pfizer’s Debt
Barron's
Pfizer
Generic Drugs Continue To Challenge Big Pharma
Generic Drugs Continue To Challenge Big Pharma
Seeking Alpha
generics
Bristol-Myers Signs Deal
Bristol-Myers Signs Deal
Yahoo/Zacks
Bristol-Myers Squibb
Ambrx
Fibroblast Growth Factor 21
FGF-21
Relaxin
diabetes
Healthcare: 8 Safe Bets For Dividends And Great Returns
Healthcare: 8 Safe Bets For Dividends And Great Returns
Seeking Alpha
Abbot
Merck
Eli Lilly
JNJ
Bristol-Myers Squibb
Novartis
Pfizer
AstraZeneca
Here's How Merck Is Making You So Much Cash
Here's How Merck Is Making You So Much Cash
Motley Fool
Merck
Are Pfizer's Earnings Better Than They Look?
Are Pfizer's Earnings Better Than They Look?
Motley Fool
Pfizer
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »